Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-20, Stock:JNJ, The news for the past five days is as follows:
2018-03-13: NEWS1: The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Johnson & Johnson Shareholders and a Lead Plaintiff Deadline of April 9, 2018.NEWS2: How Merck’s Diabetes Portfolio Performed in 2017.NEWS3: 3 Rules You Need for Picking Dividend Stocks.NEWS4: 3 Rules You Need for Picking Dividend Stocks.NEWS5: Noteworthy Tuesday Option Activity: PSA, EMN, JNJ.NEWS6: Noteworthy Tuesday Option Activity: PSA, EMN, JNJ.NEWS7: Why Geron Corporation Stock Is Rising Today.NEWS8: Why Geron Corporation Stock Is Rising Today.NEWS9: Lifshitz & Miller LLP Announces Investigation of 8point3 Energy Partners LP, Grandpoint Capital, Inc., Hardinge Inc., Johnson & Johnson, LJM Funds Management Ltd., Nationstar Mortgage Holdings Inc. and Patterson Companies, Inc..NEWS10: Why Geron Corporation Stock Is Rising Today.NEWS11: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2018.NEWS12: Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 14, 2018.NEWS13: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS14: Johnson & Johnson To Participate In Barclays Healthcare Conference At 10:15 AM.NEWS15: Johnson & Johnson To Participate In Barclays Healthcare Conference At 10:15 AM.NEWS16: Johnson & Johnson To Participate In Cowen Healthcare Conference At 10:00 AM ET.NEWS17: Johnson & Johnson To Participate In Cowen Healthcare Conference At 10:00 AM ET.
2018-03-14: NEWS1: South Dakota sues opioid makers as litigation swells.NEWS2: Dow Stocks Drop As Boeing, Apple Weigh; Bitcoin Dives To 1-Mo. Low.NEWS3: To stay on cutting edge, major corporations like Johnson & Johnson seek innovation within, outside their walls.NEWS4: VIG, IGN: Big ETF Inflows.NEWS5: VIG, IGN: Big ETF Inflows.NEWS6: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS7: Forget Remicade -- Here's How Johnson & Johnson Plans to Grow.NEWS8: Forget Remicade -- Here's How Johnson & Johnson Plans to Grow.NEWS9: Forget Remicade -- Here&apos;s How Johnson & Johnson Plans to Grow.NEWS10: Doctors hunt for hidden cancers with glowing dyes.
2018-03-15: NEWS1: Why Google co-founder Sergey Brin was using a robot to put sutures in synthetic tissue.NEWS2: Why Google co-founder Sergey Brin was using a robot to put sutures in synthetic tissue.NEWS3: Here's Why Shorting Geron Corporation Stock Is a Terrible Idea.NEWS4: Here's Why Shorting Geron Corporation Stock Is a Terrible Idea.NEWS5: Here&apos;s Why Shorting Geron Corporation Stock Is a Terrible Idea.NEWS6: What Analysts Recommend for Novartis in March 2018.NEWS7: Understanding the Performance of Merck’s Hospital Acute Care Drugs Noxafil and Cubicin.NEWS8: Understanding Merck’s Immunology Segment Performance in 4Q17 and 2017.
2018-03-16: NEWS1: Health Care Sector Update for 03/16/2018: GENE,GEN,JNJ,VNDA.NEWS2: Health Care Sector Update for 03/16/2018: GENE,GEN,JNJ,VNDA.NEWS3: Dow Stocks Lead As Walmart, AmEx Rise But GE And Apple Sit Out.NEWS4: Health Care Sector Update for 03/16/2018: VNDA,JNJ.NEWS5: Health Care Sector Update for 03/16/2018: VNDA,JNJ.NEWS6: Pharma Stock Roundup: ABBV's Elagolix Meets Study Goal, MRK's Keytruda in Focus.NEWS7: Pharma Stock Roundup: ABBV's Elagolix Meets Study Goal, MRK's Keytruda in Focus.NEWS8: Johnson & Johnson nears diabetes device exit with $2.1 billion LifeScan sale.NEWS9: Is the Tax Repeal Only Glitter and No Gold for MedTech?.NEWS10: Is the Tax Repeal Only Glitter and No Gold for MedTech?.NEWS11: Notable ETF Inflow Detected - VTV, JPM, JNJ, UNH.NEWS12: Notable ETF Inflow Detected - VTV, JPM, JNJ, UNH.NEWS13: J&J nears diabetes device exit with $2.1 bln LifeScan sale.NEWS14: Johnson & Johnson nears diabetes device exit with $2.1 billion LifeScan sale.NEWS15: Pharma Stock Roundup: ABBV&apos;s Elagolix Meets Study Goal, MRK&apos;s Keytruda in Focus.NEWS16: Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?.NEWS17: J&J's (JNJ) Erdafitinib Gets Breakthrough Therapy Status.NEWS18: J&J's (JNJ) Erdafitinib Gets Breakthrough Therapy Status.NEWS19: Health Care Sector Update for 03/16/2018: JNJ, GEN, VNDA, GENE, NBRV, BIOS.NEWS20: Health Care Sector Update for 03/16/2018: JNJ, GEN, VNDA, GENE, NBRV, BIOS.NEWS21: A Closer Look at Pfizer’s 4Q17 Growth Drivers.NEWS22: [$$] J&J Gets $2.1 Billion Offer for Blood Glucose Monitoring Business.NEWS23: J&J says offered $2.1 bln for Lifescan diabetes business.NEWS24: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS25: J&J says it&apos;s received a $2.1 billion bid for LifeScan diabetes business.NEWS26: J&J says it's received a $2.1 billion bid for LifeScan diabetes business.NEWS27: J&J Reaches $2.1 Billion Deal to Sell Diabetes Device Business.NEWS28: Stocks making the biggest moves premarket: TIF, JNJ, ADBE, ULTA, WMT, NKE & more.NEWS29: Stocks making the biggest moves premarket: TIF, JNJ, ADBE, ULTA, WMT, NKE & more.NEWS30: J&J says offered $2.1 bln for Lifescan diabetes business.NEWS31: Johnson & Johnson says Platinum Equity has offered to buy LifeScan for $2.1 billion.NEWS32: Johnson & Johnson says Platinum Equity has offered to buy LifeScan for $2.1 billion.NEWS33: Platinum Equity Submits Binding Offer to Acquire LifeScan From Johnson & Johnson.NEWS34: Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc..NEWS35: J&J&apos;s (JNJ) Erdafitinib Gets Breakthrough Therapy Status.NEWS36: J&J Gets Binding Offer From Platinum Equity To Buy LifeScan Unit For $2.1 Bln.NEWS37: J&J Gets Binding Offer From Platinum Equity To Buy LifeScan Unit For $2.1 Bln.
2018-03-19: NEWS1: This Biotech Stock Catapulted After Its Pain Drug Trumped A Key Rival.NEWS2: Is Pfizer's CEO Ian Read Really Worth 61% More?.NEWS3: Is Pfizer's CEO Ian Read Really Worth 61% More?.NEWS4: Here's Why Geron Corporation Stock Popped Today.NEWS5: Here's Why Geron Corporation Stock Popped Today.NEWS6: Is Pfizer&apos;s CEO Ian Read Really Worth 61% More?.NEWS7: J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit.NEWS8: J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit.NEWS9: Here Why Geron Corporation Stock Popped Today.NEWS10: Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up.NEWS11: Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up.NEWS12: Orthopedic Device Market Gains Momentum: 3 Stocks in Focus.NEWS13: Orthopedic Device Market Gains Momentum: 3 Stocks in Focus.NEWS14: Greenpeace says brands refusing to reveal palm oil sources.NEWS15: Greenpeace says brands refusing to reveal palm oil sources.NEWS16: 10 Can’t-Miss Dividend Hikes Coming This April.NEWS17: 10 Can’t-Miss Dividend Hikes Coming This April.NEWS18: J&J Gets $2.1B Offer for LifeScan Diabetes Device Unit.NEWS19: Orthopedic Device Market Gains Momentum: 3 Stocks in Focus.NEWS20: Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up.NEWS21: 10 Stocks To Buy For Big April Dividend Hikes.NEWS22: [$$] Multinationals fail to name palm-oil producers.NEWS23: See what the IHS Markit Score report has to say about Johnson & Johnson..

Answer: Rise